NewsDesk @bactiman63 The Statens Serum Institut has found two cases of monkey smallpox in Denmark. Both cases are related to travel to Spain. The infected are in isolation. The first case of monkey...

By NewsDesk  @infectiousdiseasenews Bavarian Nordic A/S  announced Friday that the Company was recently engaged by Public Health England (PHE) and the Medicines and Health Products Regulatory Agency...

Bavarian Nordic A/S  announced today that the Public Health Agency of Canada (PHAC) has ordered IMVAMUNE® smallpox vaccine to the national stockpile at a total value of USD 31.2 million. Deliveries...

Bavarian Nordic A/S announced today that Health Canada has expanded the approval of the Company’s non-replicating smallpox vaccine, IMVAMUNE® to include additional indications – specifically, monkeypox...

Bavarian Nordic A/S  announced  topline results from the pivotal Phase 3 study of the freeze-dried formulation of its MVA-BN® smallpox vaccine. The Phase 3 lot-consistency study was agreed with the...

By NewsDesk  @infectiousdiseasenews In this video, I take a look at the rare, viral infection in humans, and cows for that matter, cowpox. I look at the infection in cattle, in humans and in cats–the...

During a press briefing at United Nations Information Service in Geneva, the following was commemorated: Dr. Rosamund Lewis, Head of the Smallpox Secretariat at the World Health Organization (WHO), said...

Bavarian Nordic A/S today announced that the U.S. Food and Drug Administration (FDA) has approved JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) (MVA-BN®, liquid-frozen) for prevention...

Bavarian Nordic A/S announced today the initiation of a pivotal Phase 3 trial of the freeze-dried formulation of MVA-BN® smallpox vaccine in 1,110 healthy, vaccinia-naïve subjects. The randomized,...

After the confirmation on Friday 7thSeptember 2018 of the first case of human monkeypox in England, Public Health England (PHE), as part of their response, engaged Bavarian Nordic to assist in the supply...